ABCL
Price
$2.21
Change
-$0.13 (-5.58%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
657.06M
63 days until earnings call
ZURA
Price
$1.18
Change
-$0.09 (-7.14%)
Updated
Mar 10, 03:27 PM (EDT)
Capitalization
82.27M
Ad is loading...

ABCL vs ZURA

Header iconABCL vs ZURA Comparison
Open Charts ABCL vs ZURABanner chart's image
AbCellera Biologics
Price$2.21
Change-$0.13 (-5.58%)
Volume$73.55K
Capitalization657.06M
Zura Bio
Price$1.18
Change-$0.09 (-7.14%)
Volume$100
Capitalization82.27M
ABCL vs ZURA Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ZURA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and ZURA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ABCL: $2.34 vs. ZURA: $1.15)
Brand notoriety: ABCL and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 121% vs. ZURA: 73%
Market capitalization -- ABCL: $657.06M vs. ZURA: $77.37M
ABCL [@Biotechnology] is valued at $657.06M. ZURA’s [@Biotechnology] market capitalization is $77.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • ZURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZURA is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -17.02% price change this week, while ZURA (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

ZURA is expected to report earnings on Mar 28, 2023.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($657M) has a higher market cap than ZURA($82.3M). ABCL YTD gains are higher at: -20.137 vs. ZURA (-54.000). ZURA has higher annual earnings (EBITDA): -50.28M vs. ABCL (-202.4M). ABCL has more cash in the bank: 643M vs. ZURA (188M). ABCL has higher revenues than ZURA: ABCL (33M) vs ZURA (0).
ABCLZURAABCL / ZURA
Capitalization657M82.3M798%
EBITDA-202.4M-50.28M403%
Gain YTD-20.137-54.00037%
P/E RatioN/A7.96-
Revenue33M0-
Total Cash643M188M342%
Total Debt71.4MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABCLZURA
RSI
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 7 days ago
52%
Momentum
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 7 days ago
56%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
68%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 7 days ago
50%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
70%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-0.85%
CRSP - ABCL
56%
Loosely correlated
+2.74%
NTLA - ABCL
55%
Loosely correlated
-3.76%
PRME - ABCL
53%
Loosely correlated
-1.34%
ABSI - ABCL
53%
Loosely correlated
-4.39%
BEAM - ABCL
52%
Loosely correlated
+5.34%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with BIESF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-1.71%
BIESF - ZURA
40%
Loosely correlated
N/A
NKTX - ZURA
36%
Loosely correlated
+1.85%
PDSB - ZURA
32%
Poorly correlated
+6.61%
CGEM - ZURA
32%
Poorly correlated
+1.63%
CGON - ZURA
30%
Poorly correlated
-1.20%
More